| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 2.31e-07 | 28 | 98 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.42e-07 | 35 | 98 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 3.72e-06 | 48 | 98 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 4.13e-06 | 49 | 98 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | A2M SERPINE3 RASA1 UACA UGT1A10 UGT1A8 UGT1A7 UGT1A9 BIRC6 UGT1A1 A2ML1 PZP GPRC5B | 6.89e-06 | 596 | 98 | 13 | GO:0140678 |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 9.43e-06 | 9 | 98 | 3 | GO:0015379 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | A2M SERPINE3 UGT1A10 UGT1A8 UGT1A7 UGT1A9 BIRC6 UGT1A1 A2ML1 PZP GPRC5B | 9.45e-06 | 435 | 98 | 11 | GO:0004857 |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.81e-05 | 66 | 98 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 2.25e-05 | 69 | 98 | 5 | GO:0045309 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 2.44e-05 | 12 | 98 | 3 | GO:0008519 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 CELSR3 OR51Q1 ACKR3 FZD10 C5AR1 OR2V2 GPRC5B | 2.57e-05 | 884 | 98 | 15 | GO:0004930 |
| GeneOntologyMolecularFunction | odorant binding | 3.84e-05 | 127 | 98 | 6 | GO:0005549 | |
| GeneOntologyMolecularFunction | steroid binding | 4.97e-05 | 133 | 98 | 6 | GO:0005496 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 OR2V2 | 5.10e-05 | 431 | 98 | 10 | GO:0004984 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 8.17e-05 | 211 | 98 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.08e-04 | 153 | 98 | 6 | GO:0008194 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.84e-04 | 107 | 98 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.89e-04 | 23 | 98 | 3 | GO:0015377 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 2.36e-04 | 5 | 98 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 2.75e-04 | 26 | 98 | 3 | GO:0015296 | |
| GeneOntologyMolecularFunction | phosphoprotein binding | 2.79e-04 | 117 | 98 | 5 | GO:0051219 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8U1 HTR3A OR5G3 OR2J1 OR2J2 PLXND1 OR8U9 OR8U8 OR8B8 OR5AC2 CELSR3 OR51Q1 ACKR3 FZD10 C5AR1 OR2V2 GPRC5B | 2.93e-04 | 1353 | 98 | 17 | GO:0004888 |
| GeneOntologyMolecularFunction | fatty acid binding | 3.69e-04 | 69 | 98 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | C-X-C chemokine binding | 4.93e-04 | 7 | 98 | 2 | GO:0019958 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 5.46e-04 | 288 | 98 | 7 | GO:0016757 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 1.27e-03 | 11 | 98 | 2 | GO:0099122 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 1.52e-03 | 12 | 98 | 2 | GO:0050815 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 1.79e-03 | 105 | 98 | 4 | GO:0004867 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.94e-03 | 180 | 98 | 5 | GO:0004866 | |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 2.01e-03 | 51 | 98 | 3 | GO:0001784 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.30e-03 | 187 | 98 | 5 | GO:0030414 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.81e-03 | 119 | 98 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 3.13e-03 | 201 | 98 | 5 | GO:0061135 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 3.47e-03 | 398 | 98 | 7 | GO:0046982 | |
| GeneOntologyMolecularFunction | protein kinase binding | SLC12A6 CACNB3 RASA1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 IRS1 SLC12A5 SLC12A4 GPRC5B | 3.66e-03 | 873 | 98 | 11 | GO:0019901 |
| GeneOntologyMolecularFunction | enzyme regulator activity | A2M RANBP2 SERPINE3 RASA1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 IRS1 BIRC6 UGT1A1 A2ML1 PZP RASAL1 GPRC5B | 3.76e-03 | 1418 | 98 | 15 | GO:0030234 |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 4.28e-03 | 20 | 98 | 2 | GO:0061608 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 CACNB3 NDUFS7 HTR3A SLC12A5 SLC5A4 SLC12A4 UCP3 SCNN1B | 5.34e-03 | 664 | 98 | 9 | GO:0008324 |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.24e-11 | 6 | 97 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | TPO UGT1A10 UGT1A8 CYP11B2 UGT1A7 UGT1A9 FOXA1 UGT1A1 LHB DUOX1 DGAT2 SCNN1B PCSK4 | 8.80e-10 | 286 | 97 | 13 | GO:0042445 |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 2.29e-09 | 5 | 97 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 2.29e-09 | 5 | 97 | 4 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.59e-09 | 13 | 97 | 5 | GO:0009812 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 6.84e-09 | 6 | 97 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 6.84e-09 | 6 | 97 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 3.97e-08 | 21 | 97 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 9.44e-08 | 10 | 97 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 9.44e-08 | 10 | 97 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.26e-07 | 26 | 97 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.26e-07 | 26 | 97 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.21e-07 | 12 | 97 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 8.02e-07 | 37 | 97 | 5 | GO:0055075 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 2.59e-06 | 21 | 97 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | TPO UGT1A10 UGT1A8 CYP11B2 UGT1A7 UGT1A9 IRS1 FOXA1 UGT1A1 LHB DUOX1 DGAT2 SCNN1B PCSK4 | 3.75e-06 | 684 | 97 | 14 | GO:0010817 |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 4.52e-06 | 52 | 97 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 SCNN1B C5AR1 OR2V2 | 9.86e-06 | 547 | 97 | 12 | GO:0007606 |
| GeneOntologyBiologicalProcess | steroid metabolic process | UGT1A10 UGT1A8 CYP11B2 UGT1A7 UGT1A9 BDH1 UGT1A1 LHB DGAT2 SCNN1B | 1.11e-05 | 376 | 97 | 10 | GO:0008202 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 1.59e-05 | 67 | 97 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.91e-05 | 34 | 97 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 2.19e-05 | 2 | 97 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 2.19e-05 | 2 | 97 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 2.79e-05 | 13 | 97 | 3 | GO:0072488 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 OR2V2 | 3.63e-05 | 432 | 97 | 10 | GO:0050911 |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 3.69e-05 | 40 | 97 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | sensory perception | CACNB3 OR8U1 MAP1A OR5G3 OR2J1 OR2J2 TULP2 OR8U9 OR8U8 OR8B8 SLC52A3 OR5AC2 OR51Q1 SCNN1B C5AR1 OR2V2 | 3.79e-05 | 1072 | 97 | 16 | GO:0007600 |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 4.49e-05 | 42 | 97 | 4 | GO:0006884 | |
| GeneOntologyBiologicalProcess | ketone metabolic process | 5.18e-05 | 279 | 97 | 8 | GO:0042180 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 5.44e-05 | 141 | 97 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 6.12e-05 | 144 | 97 | 6 | GO:0006720 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 6.30e-05 | 89 | 97 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 6.55e-05 | 3 | 97 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 6.55e-05 | 3 | 97 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 6.55e-05 | 3 | 97 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 OR2V2 | 6.72e-05 | 465 | 97 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | pigment metabolic process | 8.17e-05 | 94 | 97 | 5 | GO:0042440 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 8.17e-05 | 94 | 97 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | CACNB3 OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 OR2V2 | 9.10e-05 | 582 | 97 | 11 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 OR2V2 | 9.52e-05 | 485 | 97 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 1.31e-04 | 4 | 97 | 2 | GO:0140157 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 1.31e-04 | 4 | 97 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.38e-04 | 105 | 97 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 OR2V2 | 1.79e-04 | 524 | 97 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 2.15e-04 | 25 | 97 | 3 | GO:0055064 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 3.03e-04 | 28 | 97 | 3 | GO:0055081 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 3.24e-04 | 6 | 97 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | detection of stimulus | CACNB3 OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 OR2V2 | 5.78e-04 | 722 | 97 | 11 | GO:0051606 |
| GeneOntologyBiologicalProcess | hormone biosynthetic process | 6.36e-04 | 83 | 97 | 4 | GO:0042446 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 6.36e-04 | 222 | 97 | 6 | GO:0071466 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 LHB OR5AC2 CELSR3 OR51Q1 ACKR3 FZD10 C5AR1 OR2V2 GPRC5B | 7.61e-04 | 1395 | 97 | 16 | GO:0007186 |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | RASA1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC12A5 UGT1A1 N6AMT1 SCNN1B | 8.22e-04 | 525 | 97 | 9 | GO:0009410 |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.24e-03 | 45 | 97 | 3 | GO:0008207 | |
| GeneOntologyBiologicalProcess | gland development | 1.26e-03 | 558 | 97 | 9 | GO:0048732 | |
| Domain | UDPGT | 6.49e-08 | 21 | 97 | 5 | PF00201 | |
| Domain | UDPGT | 6.49e-08 | 21 | 97 | 5 | PS00375 | |
| Domain | UDP_glucos_trans | 6.49e-08 | 21 | 97 | 5 | IPR002213 | |
| Domain | KCL_cotranspt | 5.41e-07 | 4 | 97 | 3 | IPR000076 | |
| Domain | AA-permease/SLC12A_dom | 4.65e-06 | 22 | 97 | 4 | IPR004841 | |
| Domain | AA_permease | 4.65e-06 | 22 | 97 | 4 | PF00324 | |
| Domain | SLC12A_fam | 4.68e-06 | 7 | 97 | 3 | IPR004842 | |
| Domain | SLC12_C | 7.46e-06 | 8 | 97 | 3 | IPR018491 | |
| Domain | SLC12 | 7.46e-06 | 8 | 97 | 3 | PF03522 | |
| Domain | A2M_N | 1.59e-05 | 10 | 97 | 3 | PF01835 | |
| Domain | A2M_N | 1.59e-05 | 10 | 97 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.59e-05 | 10 | 97 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.59e-05 | 10 | 97 | 3 | PS00477 | |
| Domain | A2M | 1.59e-05 | 10 | 97 | 3 | PF00207 | |
| Domain | A2M_N_2 | 1.59e-05 | 10 | 97 | 3 | IPR011625 | |
| Domain | A2M_comp | 1.59e-05 | 10 | 97 | 3 | IPR011626 | |
| Domain | A2M_N_2 | 1.59e-05 | 10 | 97 | 3 | PF07703 | |
| Domain | A2M_recep | 1.59e-05 | 10 | 97 | 3 | PF07677 | |
| Domain | A2M_comp | 1.59e-05 | 10 | 97 | 3 | PF07678 | |
| Domain | Macroglobln_a2 | 1.59e-05 | 10 | 97 | 3 | IPR001599 | |
| Domain | KCC1 | 2.67e-05 | 2 | 97 | 2 | IPR000622 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.05e-04 | 18 | 97 | 3 | IPR008930 | |
| Domain | Olfact_rcpt | 2.06e-04 | 393 | 97 | 9 | IPR000725 | |
| Domain | RNA_pol_II-bd | 5.51e-04 | 7 | 97 | 2 | IPR006903 | |
| Domain | CTD_bind | 5.51e-04 | 7 | 97 | 2 | PF04818 | |
| Domain | RPR | 7.32e-04 | 8 | 97 | 2 | SM00582 | |
| Domain | Thiol-ester_cl | 7.32e-04 | 8 | 97 | 2 | PF10569 | |
| Domain | CID | 7.32e-04 | 8 | 97 | 2 | PS51391 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 7.32e-04 | 8 | 97 | 2 | IPR019565 | |
| Domain | CID_dom | 7.32e-04 | 8 | 97 | 2 | IPR006569 | |
| Domain | MacrogloblnA2_CS | 7.32e-04 | 8 | 97 | 2 | IPR019742 | |
| Domain | A2M_N_2 | 7.32e-04 | 8 | 97 | 2 | SM01359 | |
| Domain | - | 7.32e-04 | 8 | 97 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 7.32e-04 | 8 | 97 | 2 | SM01361 | |
| Domain | A2M | 7.32e-04 | 8 | 97 | 2 | SM01360 | |
| Domain | 7tm_1 | OR8U1 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 ACKR3 C5AR1 OR2V2 | 7.68e-04 | 677 | 97 | 11 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8U1 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 ACKR3 C5AR1 OR2V2 | 8.46e-04 | 685 | 97 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8U1 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 ACKR3 C5AR1 OR2V2 | 9.08e-04 | 691 | 97 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8U1 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 ACKR3 C5AR1 OR2V2 | 9.19e-04 | 692 | 97 | 11 | IPR000276 |
| Domain | Haem_peroxidase | 1.17e-03 | 10 | 97 | 2 | IPR010255 | |
| Domain | An_peroxidase | 1.17e-03 | 10 | 97 | 2 | PF03098 | |
| Domain | PEROXIDASE_3 | 1.17e-03 | 10 | 97 | 2 | PS50292 | |
| Domain | Haem_peroxidase_animal | 1.17e-03 | 10 | 97 | 2 | IPR019791 | |
| Domain | - | 1.17e-03 | 10 | 97 | 2 | 1.10.640.10 | |
| Domain | - | 1.70e-03 | 12 | 97 | 2 | 1.50.10.20 | |
| Domain | RasGAP | 2.33e-03 | 14 | 97 | 2 | SM00323 | |
| Domain | IMPORTIN_B_NT | 2.33e-03 | 14 | 97 | 2 | PS50166 | |
| Domain | RasGAP_CS | 2.33e-03 | 14 | 97 | 2 | IPR023152 | |
| Domain | GPCR_Rhodpsn_7TM | OR8U1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 ACKR3 C5AR1 OR2V2 | 2.51e-03 | 670 | 97 | 10 | IPR017452 |
| Domain | RasGAP | 2.68e-03 | 15 | 97 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 2.68e-03 | 15 | 97 | 2 | PS00509 | |
| Domain | IBN_N | 2.68e-03 | 15 | 97 | 2 | PF03810 | |
| Domain | RAS_GTPASE_ACTIV_2 | 2.68e-03 | 15 | 97 | 2 | PS50018 | |
| Domain | - | 3.06e-03 | 16 | 97 | 2 | 1.10.506.10 | |
| Domain | IBN_N | 3.06e-03 | 16 | 97 | 2 | SM00913 | |
| Domain | Importin-beta_N | 3.45e-03 | 17 | 97 | 2 | IPR001494 | |
| Domain | RasGAP_dom | 3.87e-03 | 18 | 97 | 2 | IPR001936 | |
| Pathway | WP_ESTROGEN_METABOLISM | 8.54e-08 | 22 | 74 | 5 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.37e-07 | 24 | 74 | 5 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.70e-07 | 25 | 74 | 5 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.70e-07 | 25 | 74 | 5 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.70e-07 | 25 | 74 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 2.10e-07 | 26 | 74 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 3.11e-07 | 28 | 74 | 5 | M19580 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 4.03e-07 | 55 | 74 | 6 | M14933 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 6.73e-07 | 14 | 74 | 4 | M39328 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.00e-06 | 64 | 74 | 6 | M9488 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.74e-06 | 39 | 74 | 5 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.25e-06 | 41 | 74 | 5 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.61e-06 | 45 | 74 | 5 | MM15694 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 4.79e-06 | 7 | 74 | 3 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 4.79e-06 | 7 | 74 | 3 | MM15081 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 6.76e-06 | 51 | 74 | 5 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 7.45e-06 | 52 | 74 | 5 | M14171 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.87e-05 | 219 | 74 | 8 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.93e-05 | 220 | 74 | 8 | M10320 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.02e-05 | 107 | 74 | 6 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.25e-05 | 109 | 74 | 6 | M18788 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 2.95e-05 | 12 | 74 | 3 | M39611 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.23e-05 | 70 | 74 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.70e-05 | 72 | 74 | 5 | M9257 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 OR2V2 | 6.10e-05 | 417 | 74 | 10 | M4072 |
| Pathway | REACTOME_ASPIRIN_ADME | 8.10e-05 | 44 | 74 | 4 | M45014 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 8.86e-05 | 45 | 74 | 4 | M39615 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 1.11e-04 | 145 | 74 | 6 | M45512 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.49e-04 | 153 | 74 | 6 | MM15844 | |
| Pathway | REACTOME_DRUG_ADME | 2.66e-04 | 109 | 74 | 5 | M45012 | |
| Pathway | REACTOME_DRUG_ADME | 3.99e-04 | 119 | 74 | 5 | MM15692 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 4.02e-04 | 6 | 74 | 2 | M27075 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8U1 OR5G3 OR2J1 OR2J2 OR8U9 OR8U8 OR8B8 OR5AC2 OR51Q1 SCNN1B OR2V2 | 4.53e-04 | 636 | 74 | 11 | M41834 |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.60e-04 | 29 | 74 | 3 | M45015 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 5.62e-04 | 31 | 74 | 3 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 6.17e-04 | 32 | 74 | 3 | M39567 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 7.46e-04 | 8 | 74 | 2 | M47935 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 9.56e-04 | 9 | 74 | 2 | MM14833 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 1.19e-03 | 10 | 74 | 2 | M27120 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 1.73e-03 | 12 | 74 | 2 | MM14749 | |
| Pubmed | 9.59e-13 | 6 | 98 | 5 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.35e-12 | 7 | 98 | 5 | 8467709 | |
| Pubmed | 3.35e-12 | 7 | 98 | 5 | 8464825 | ||
| Pubmed | 8.91e-12 | 8 | 98 | 5 | 17179145 | ||
| Pubmed | 8.91e-12 | 8 | 98 | 5 | 20610558 | ||
| Pubmed | 8.91e-12 | 8 | 98 | 5 | 18052087 | ||
| Pubmed | 2.00e-11 | 9 | 98 | 5 | 22511988 | ||
| Pubmed | 3.99e-11 | 10 | 98 | 5 | 23642732 | ||
| Pubmed | 3.99e-11 | 10 | 98 | 5 | 11465080 | ||
| Pubmed | 3.99e-11 | 10 | 98 | 5 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.99e-11 | 10 | 98 | 5 | 22558097 | |
| Pubmed | 5.93e-11 | 4 | 98 | 4 | 17558305 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.25e-10 | 12 | 98 | 5 | 20308471 | |
| Pubmed | 1.25e-10 | 12 | 98 | 5 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.25e-10 | 12 | 98 | 5 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 2.03e-10 | 13 | 98 | 5 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2.03e-10 | 13 | 98 | 5 | 25246029 | |
| Pubmed | 3.14e-10 | 14 | 98 | 5 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 3.14e-10 | 14 | 98 | 5 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 3.14e-10 | 14 | 98 | 5 | 14672974 | |
| Pubmed | 3.14e-10 | 14 | 98 | 5 | 9295054 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 6.83e-10 | 16 | 98 | 5 | 19414484 | |
| Pubmed | 8.85e-10 | 6 | 98 | 4 | 32527940 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 9.65e-10 | 17 | 98 | 5 | 20639394 | |
| Pubmed | 1.33e-09 | 18 | 98 | 5 | 20056724 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.81e-09 | 19 | 98 | 5 | 23281178 | |
| Pubmed | 2.06e-09 | 7 | 98 | 4 | 27514509 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 6.53e-09 | 24 | 98 | 5 | 24625756 | |
| Pubmed | 1.93e-08 | 11 | 98 | 4 | 18695635 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 19364970 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 29519853 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 16636344 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 26247833 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 2.17e-08 | 3 | 98 | 3 | 24453052 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 12183561 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 23789755 | ||
| Pubmed | Alpha-2 macroglobulin controls trophoblast positioning in mouse implantation sites. | 2.17e-08 | 3 | 98 | 3 | 14580373 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 17406868 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 19996319 | ||
| Pubmed | alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis. | 2.17e-08 | 3 | 98 | 3 | 10487856 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 12847094 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 27031383 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 20628391 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 8.66e-08 | 4 | 98 | 3 | 2108603 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 12637262 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.58e-07 | 211 | 98 | 8 | 24097068 | |
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 2.16e-07 | 5 | 98 | 3 | 18597651 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 7514554 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 20565459 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 15057901 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 4.31e-07 | 6 | 98 | 3 | 19204906 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 5.97e-07 | 57 | 98 | 5 | 21886157 | |
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 1.20e-06 | 8 | 98 | 3 | 12695355 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 1.20e-06 | 8 | 98 | 3 | 24393035 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 1.20e-06 | 8 | 98 | 3 | 21613606 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 15319294 | ||
| Pubmed | 1.25e-06 | 66 | 98 | 5 | 19898482 | ||
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 1.80e-06 | 9 | 98 | 3 | 7544347 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 1.80e-06 | 9 | 98 | 3 | 20732626 | |
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 1339448 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 19323993 | ||
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 4.69e-06 | 12 | 98 | 3 | 19349540 | |
| Pubmed | Nup358 and Transportin 1 Cooperate in Adenoviral Genome Import. | 7.86e-06 | 2 | 98 | 2 | 32161167 | |
| Pubmed | Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. | 7.86e-06 | 2 | 98 | 2 | 15864130 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15929176 | ||
| Pubmed | Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population. | 7.86e-06 | 2 | 98 | 2 | 31132973 | |
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 7.86e-06 | 2 | 98 | 2 | 34031912 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9627603 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9639672 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9621515 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8226884 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12087094 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18675828 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18349289 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 10946897 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18981166 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 7528167 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 1840592 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25547628 | ||
| Pubmed | Transportin-1 and Transportin-2: protein nuclear import and beyond. | 7.86e-06 | 2 | 98 | 2 | 24780099 | |
| Pubmed | Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. | 7.86e-06 | 2 | 98 | 2 | 7715297 | |
| Pubmed | Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases. | 7.86e-06 | 2 | 98 | 2 | 7989045 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8706880 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 1692292 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 7906695 | ||
| Pubmed | Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38. | 7.86e-06 | 2 | 98 | 2 | 15286088 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18454993 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 11901093 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 11677206 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 17510708 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22031623 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 31104839 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 11061796 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18430559 | ||
| Pubmed | Novel missense mutation of the UGT1A1 gene in Thai siblings with Gilbert's syndrome. | 7.86e-06 | 2 | 98 | 2 | 12139570 | |
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 7.86e-06 | 2 | 98 | 2 | 10497143 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 2578455 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18568343 | ||
| Pubmed | Rhox homeobox gene cluster: recent duplication of three family members. | 7.86e-06 | 2 | 98 | 2 | 16496311 | |
| Cytoband | 2q37 | 6.50e-09 | 31 | 98 | 5 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 9.61e-06 | 226 | 98 | 6 | chr2q37 | |
| GeneFamily | UDP glucuronosyltransferases | 3.10e-07 | 32 | 82 | 5 | 363 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 7.41e-06 | 9 | 82 | 3 | 1234 | |
| GeneFamily | Olfactory receptors, family 8 | 7.13e-05 | 49 | 82 | 4 | 155 | |
| GeneFamily | Solute carriers | 4.21e-04 | 395 | 82 | 8 | 752 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 8.93e-04 | 10 | 82 | 2 | 830 | |
| GeneFamily | Armadillo repeat containing|Importins | 2.97e-03 | 18 | 82 | 2 | 596 | |
| ToppCell | Basal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.00e-05 | 166 | 96 | 5 | 23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 3.18e-05 | 168 | 96 | 5 | d5b746d6083c2c8155a0ea345ea368bf6617d5ca | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 170 | 96 | 5 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.30e-05 | 179 | 96 | 5 | 798f208014f2229c597934775646ddbbacf94b69 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-05 | 181 | 96 | 5 | 08bc6fe2a11d31a7e5e4a4552b04c0ebc2aefc59 | |
| ToppCell | Control-Myeloid-Alveolar_macrophages|Control / group, cell type (main and fine annotations) | 4.53e-05 | 181 | 96 | 5 | 8d2102c8c86c59a82610f26f90946b290552e666 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-05 | 182 | 96 | 5 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic|GI_small-bowel / Manually curated celltypes from each tissue | 4.77e-05 | 183 | 96 | 5 | 6109199cf25b28831193a5ed7925b5bf38c6eb43 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.90e-05 | 184 | 96 | 5 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.90e-05 | 184 | 96 | 5 | 315bb14e848d8e8e4533122047df6f9b89b89d99 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-05 | 185 | 96 | 5 | f8de11dd53b34d36368a2082f24ec1416cb7dbae | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-05 | 185 | 96 | 5 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 5.16e-05 | 186 | 96 | 5 | a0cc925af97e47efd0c9bc17c37963e8ad4e5b35 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 187 | 96 | 5 | cfdc1585c80d2bb475d9145395fb50a88c53f838 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.29e-05 | 187 | 96 | 5 | d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 187 | 96 | 5 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 189 | 96 | 5 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.56e-05 | 189 | 96 | 5 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 189 | 96 | 5 | b8cbfc47f3f40b6fccd15899d58c87d07b0001aa | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.85e-05 | 191 | 96 | 5 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 191 | 96 | 5 | 65083daf317f66556dc047eb19297dcbe9c70299 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.99e-05 | 192 | 96 | 5 | 5a0615fdc217554ccd611504b16e5d97628e207d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.99e-05 | 192 | 96 | 5 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.99e-05 | 192 | 96 | 5 | 97c312c82ec025c13052f8d424b11c0034c8ea54 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 192 | 96 | 5 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | Monocytes-C1QA+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.30e-05 | 194 | 96 | 5 | 3e104e85574894c04791252d466d438fc809dde3 | |
| ToppCell | CF-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 6.30e-05 | 194 | 96 | 5 | 3feb8a0ba3368673c53e9cbd4980e73d18697718 | |
| ToppCell | 343B-Myeloid-Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 195 | 96 | 5 | 48ba2044d2459c8b0d17bc7deca8d0195ac6a00e | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-05 | 196 | 96 | 5 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.61e-05 | 196 | 96 | 5 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-05 | 196 | 96 | 5 | a0ba408b802fa6d6e42e6d234b6879fdb1583f81 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.61e-05 | 196 | 96 | 5 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | Monocytes-IL1B+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.61e-05 | 196 | 96 | 5 | 7bc0735d324ac5a1661434cda4116ddd58296730 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.61e-05 | 196 | 96 | 5 | 889c9fed857f64664ca1f47fcec9fecb15ed103c | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 197 | 96 | 5 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 6.77e-05 | 197 | 96 | 5 | 598fb7a9a8400af49d90807b3155d3cc1c34f505 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-05 | 197 | 96 | 5 | 86a02fd7b4762b3278e5e60b5483b5fc1206e597 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-05 | 197 | 96 | 5 | e698a0bbb20bd4868ff4348f2ac9f609942b55fa | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-05 | 197 | 96 | 5 | 947042f888335c0829d4d5daeb623973eadb3348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 198 | 96 | 5 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 198 | 96 | 5 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 198 | 96 | 5 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.93e-05 | 198 | 96 | 5 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.93e-05 | 198 | 96 | 5 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CCL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | 52c06fcc112da21b1d914a896c04bde06fc756fe | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-05 | 199 | 96 | 5 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 7.10e-05 | 199 | 96 | 5 | 8990a3d69e24cb3aaba9d6def3d0be9ee973436d | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 7.10e-05 | 199 | 96 | 5 | 96070b5ffcbab4952970f43b536969ddd2ca5d14 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-05 | 199 | 96 | 5 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | 54167894a16e975d0541cbe3e515bcfa183044f6 | |
| ToppCell | metastatic_Brain-Myeloid_cells|metastatic_Brain / Location, Cell class and cell subclass | 7.10e-05 | 199 | 96 | 5 | fdda25d26a5203bac00758ed6954638727ad194f | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.10e-05 | 199 | 96 | 5 | 60e6312a149e23e4b486d92fb1f9625960b69c9d | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.10e-05 | 199 | 96 | 5 | 97052c28e354833901f28d339b09f97f50a5b752 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | 4b6d49b96bfcd6604b082bab620ae03276520885 | |
| ToppCell | Transverse-Macrophage-Macrophage|Transverse / Region, Cell class and subclass | 7.27e-05 | 200 | 96 | 5 | 17548806ba38008050244151d1216c69ef8a8310 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 980cb0390586d8312890e8d0f3cf58e3309d16c5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Transverse-(6)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 7.27e-05 | 200 | 96 | 5 | b28350de555fa756d2631f004f71d5ac69b1affe | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 1a080564de59abd59d3208a73441b6346e1c7cd8 | |
| ToppCell | IIH-mono1-|IIH / Condition, Cell_class and T cell subcluster | 7.27e-05 | 200 | 96 | 5 | 555207143ecc89cdd55c30a513b31cf5dfd26dbc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 4b4df0fe47498310d94448b8a289e58e4f5b5aa8 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Transverse-Macrophage|Transverse / Region, Cell class and subclass | 7.27e-05 | 200 | 96 | 5 | 1920605e5811938814d02b971069a4506868db5f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 77a68e8fd97a3f3467d25032067fd7ad52ab8522 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | d7d971586c01152b3d21956fd98280588cb8f08b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.27e-05 | 200 | 96 | 5 | 838f87cc55652512d240c5952ee4b3870fb2399f | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | efdbd1273b07d9fe957380e347b5b6b45db0a271 | |
| ToppCell | IIH-mono1|IIH / Condition, Cell_class and T cell subcluster | 7.27e-05 | 200 | 96 | 5 | 85c090fa714a6a02703ed38d3d49788ec0119666 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 9ca86928fceaa1fefd0f9ffcfa5cc0a210ee5792 | |
| ToppCell | Transverse-(6)_Macrophage-(60)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 7.27e-05 | 200 | 96 | 5 | 2be675684a2958ea609939bb45248bede78a26bc | |
| ToppCell | metastatic_Brain-Myeloid_cells-mo-Mac|metastatic_Brain / Location, Cell class and cell subclass | 7.27e-05 | 200 | 96 | 5 | 8f702d518f652782b0dd6ca3bdd965a79deb61f3 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.37e-04 | 121 | 96 | 4 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.02e-04 | 134 | 96 | 4 | 917b8951dd4c870b6b92f2e73e02dac884330c30 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-04 | 139 | 96 | 4 | 96e6fed23e7a69f678f85e8e2fe77a7491586b4b | |
| ToppCell | Control-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-04 | 145 | 96 | 4 | bab85a72142b6257f7d424e5301f65b6dcdf745d | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.80e-04 | 146 | 96 | 4 | f7349d63bb47f1f22ced8ff514edc1c11bc782e7 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Cxcl14_(dSPN,_lateral_striatum)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.95e-04 | 60 | 96 | 3 | 64d4de1de20d07c5f2e20b76854311a31718faa4 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Cxcl14_(dSPN,_lateral_striatum)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.95e-04 | 60 | 96 | 3 | b3941f8c3cf2365c5bf79961f62c9c0c7405a67b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-04 | 148 | 96 | 4 | 12fa2c4922f03803006c606b1b16e79441e3bb13 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-04 | 149 | 96 | 4 | a6c24d8f3b5f08587f0a12cd63d166b68ea000c7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.03e-04 | 149 | 96 | 4 | c773c2b9685ec44a35246180a93456c8765353f5 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-04 | 152 | 96 | 4 | 931c10245cde9b3290224cc1da46b2bf300b9ac2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 155 | 96 | 4 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | Club-club-7|World / Class top | 3.57e-04 | 64 | 96 | 3 | df413c5328966480479c41826461c4d817fbe33d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-04 | 159 | 96 | 4 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-04 | 159 | 96 | 4 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 161 | 96 | 4 | 9f02b94e29e60d50e92eaa748ebf0c36d3671bb3 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.26e-04 | 163 | 96 | 4 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.27e-04 | 68 | 96 | 3 | ad6c363d7fb3c436e894db30a544748c5df75a45 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.27e-04 | 68 | 96 | 3 | 82d928f5eefa065d26096a84b0d78f131dcc8c73 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.27e-04 | 68 | 96 | 3 | d97199a8c6afa79bff1600f00c2dbf6286df24a2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.45e-04 | 69 | 96 | 3 | 4831573a45ace5f06cd409f0e75bce838ed65a88 | |
| ToppCell | facs-Heart-LV-24m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 165 | 96 | 4 | 41707e66542ea27133043740ef9e58ab89b06607 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 4.46e-04 | 165 | 96 | 4 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-04 | 166 | 96 | 4 | da10d0be6b616199d49dd922591c2901f9681583 | |
| Computational | Nuclear pore complex. | 6.92e-05 | 17 | 52 | 3 | MODULE_352 | |
| Drug | naringenin chalcone | 1.20e-12 | 5 | 96 | 5 | ctd:C027329 | |
| Drug | anthrarobin | 1.20e-12 | 5 | 96 | 5 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 7.17e-12 | 6 | 96 | 5 | ctd:C543211 | |
| Drug | alloin | 7.17e-12 | 6 | 96 | 5 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 7.17e-12 | 6 | 96 | 5 | ctd:C107497 | |
| Drug | 2-hydroxyestrone | 8.03e-12 | 13 | 96 | 6 | ctd:C024980 | |
| Drug | 2',4'-dihydroxychalcone | 2.50e-11 | 7 | 96 | 5 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 6.65e-11 | 8 | 96 | 5 | ctd:C034890 | |
| Drug | AC1MRQNQ | 1.49e-10 | 9 | 96 | 5 | CID003522271 | |
| Drug | DHPASiU | 1.49e-10 | 9 | 96 | 5 | CID000197602 | |
| Drug | 3-iodophenol | 1.49e-10 | 9 | 96 | 5 | CID000012272 | |
| Drug | AC1L4J7U | 1.49e-10 | 9 | 96 | 5 | CID000186631 | |
| Drug | Chebi:32663 | 1.49e-10 | 9 | 96 | 5 | CID005460873 | |
| Drug | 2,6-dihydroxyanthraquinone | 2.97e-10 | 10 | 96 | 5 | ctd:C034889 | |
| Drug | 4-nitrophenyl)imidazole | 5.43e-10 | 11 | 96 | 5 | CID000123155 | |
| Drug | AC1O5XMV | 5.43e-10 | 11 | 96 | 5 | CID006442661 | |
| Drug | N-OH-DABZ | 9.28e-10 | 12 | 96 | 5 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 9.28e-10 | 12 | 96 | 5 | CID000088735 | |
| Drug | 4-hydroxyestrone | 9.28e-10 | 12 | 96 | 5 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 9.28e-10 | 12 | 96 | 5 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 9.28e-10 | 12 | 96 | 5 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 9.28e-10 | 12 | 96 | 5 | CID000276709 | |
| Drug | tritanol | 1.50e-09 | 13 | 96 | 5 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.50e-09 | 13 | 96 | 5 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.50e-09 | 13 | 96 | 5 | CID000000411 | |
| Drug | alizarin | 1.50e-09 | 13 | 96 | 5 | ctd:C010078 | |
| Drug | propranolol glucuronide | 2.33e-09 | 14 | 96 | 5 | CID000119515 | |
| Drug | PCB-61 | 2.33e-09 | 14 | 96 | 5 | CID000036401 | |
| Drug | PCB 156 | 3.24e-09 | 31 | 96 | 6 | CID000038019 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 3.48e-09 | 15 | 96 | 5 | CID000040469 | |
| Drug | afloqualone | 3.48e-09 | 15 | 96 | 5 | CID000002040 | |
| Drug | naphthyl sulphate | 3.48e-09 | 15 | 96 | 5 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 3.48e-09 | 15 | 96 | 5 | CID000010752 | |
| Drug | bergamottin | 3.48e-09 | 15 | 96 | 5 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 3.48e-09 | 15 | 96 | 5 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 5.05e-09 | 16 | 96 | 5 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 5.05e-09 | 16 | 96 | 5 | CID000040003 | |
| Drug | bilirubin-phosphate | 5.05e-09 | 16 | 96 | 5 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 7.13e-09 | 17 | 96 | 5 | CID000003573 | |
| Drug | 6-hydroxychrysene | 7.13e-09 | 17 | 96 | 5 | CID000037766 | |
| Drug | SureCN12722713 | 9.84e-09 | 18 | 96 | 5 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 9.84e-09 | 18 | 96 | 5 | CID000152226 | |
| Drug | Br 2 | 9.84e-09 | 18 | 96 | 5 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 9.84e-09 | 18 | 96 | 5 | CID000036614 | |
| Drug | ApApG | 9.84e-09 | 18 | 96 | 5 | CID003081975 | |
| Drug | C1 11-32 | 9.84e-09 | 18 | 96 | 5 | CID000443077 | |
| Drug | C11131 | 9.84e-09 | 18 | 96 | 5 | CID000443076 | |
| Drug | 9-OH-risperidone | 1.33e-08 | 19 | 96 | 5 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.33e-08 | 19 | 96 | 5 | CID000091433 | |
| Drug | almokalant | 1.33e-08 | 19 | 96 | 5 | CID003033962 | |
| Drug | tectochrysin | 1.77e-08 | 20 | 96 | 5 | CID005281954 | |
| Drug | AC1L1OBF | 1.77e-08 | 20 | 96 | 5 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.77e-08 | 20 | 96 | 5 | CID000116545 | |
| Drug | entacapone | 1.77e-08 | 20 | 96 | 5 | ctd:C071192 | |
| Drug | testosterone glucuronide | 1.91e-08 | 41 | 96 | 6 | CID000108192 | |
| Drug | glabridin | 2.05e-08 | 8 | 96 | 4 | ctd:C107601 | |
| Drug | estriol-16-glucuronide | 2.31e-08 | 21 | 96 | 5 | CID000122281 | |
| Drug | dulcin | 2.31e-08 | 21 | 96 | 5 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 2.31e-08 | 21 | 96 | 5 | CID000069186 | |
| Drug | androsterone glucuronide | 2.58e-08 | 43 | 96 | 6 | CID000114833 | |
| Drug | amonafide | 2.98e-08 | 22 | 96 | 5 | CID000050515 | |
| Drug | N-methylpiperazine | 2.98e-08 | 22 | 96 | 5 | CID000053167 | |
| Drug | plumbagin | 2.98e-08 | 22 | 96 | 5 | ctd:C014758 | |
| Drug | amidoxime | 3.80e-08 | 23 | 96 | 5 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 3.80e-08 | 23 | 96 | 5 | CID000066651 | |
| Drug | phenanthridine | 3.80e-08 | 23 | 96 | 5 | CID000009189 | |
| Drug | AC1N8H7N | 3.93e-08 | 78 | 96 | 7 | CID004318740 | |
| Drug | AS-3201 | 4.78e-08 | 24 | 96 | 5 | CID000153948 | |
| Drug | EM-652 | 5.79e-08 | 49 | 96 | 6 | CID000155435 | |
| Drug | 5-MOP | 5.96e-08 | 25 | 96 | 5 | CID000002355 | |
| Drug | Hymecromone | 5.96e-08 | 25 | 96 | 5 | ctd:D006923 | |
| Drug | AzMC | 5.96e-08 | 25 | 96 | 5 | CID000064986 | |
| Drug | N-acetylbenzidine | 5.96e-08 | 25 | 96 | 5 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 5.96e-08 | 25 | 96 | 5 | CID000006796 | |
| Drug | N-phenylmaleimide | 5.96e-08 | 25 | 96 | 5 | CID000013662 | |
| Drug | phenylbutazone | 6.07e-08 | 83 | 96 | 7 | CID000004781 | |
| Drug | Glucuronides | 6.11e-08 | 10 | 96 | 4 | ctd:D020719 | |
| Drug | Thymol | 7.36e-08 | 26 | 96 | 5 | ctd:D013943 | |
| Drug | biochanin A | 8.42e-08 | 87 | 96 | 7 | ctd:C004541 | |
| Drug | licochalcone A | 9.00e-08 | 27 | 96 | 5 | ctd:C070840 | |
| Drug | diflunisal | 9.00e-08 | 27 | 96 | 5 | CID000003059 | |
| Drug | Scopoletin | 9.00e-08 | 27 | 96 | 5 | ctd:D012603 | |
| Drug | DiMeIQx | 9.00e-08 | 27 | 96 | 5 | CID000104739 | |
| Drug | Equol | 1.05e-07 | 54 | 96 | 6 | ctd:D060754 | |
| Drug | CARMINE | 1.09e-07 | 28 | 96 | 5 | CID000014749 | |
| Drug | erucin | 1.09e-07 | 28 | 96 | 5 | CID000078160 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.09e-07 | 28 | 96 | 5 | CID000081261 | |
| Drug | H-Ni | 1.09e-07 | 28 | 96 | 5 | CID000445665 | |
| Drug | AC1L1JAL | 1.31e-07 | 29 | 96 | 5 | CID000004954 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.31e-07 | 29 | 96 | 5 | CID000125641 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 1.31e-07 | 29 | 96 | 5 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 1.31e-07 | 29 | 96 | 5 | CID000000414 | |
| Drug | iberin | 1.31e-07 | 29 | 96 | 5 | CID000010455 | |
| Drug | 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 1.31e-07 | 29 | 96 | 5 | ctd:C060533 | |
| Drug | norclozapine | 1.46e-07 | 57 | 96 | 6 | CID000002820 | |
| Drug | tolcapone | 1.57e-07 | 30 | 96 | 5 | CID004659569 | |
| Drug | paricalcitol | 1.57e-07 | 30 | 96 | 5 | CID005281104 | |
| Drug | AC1L9E0Q | 1.57e-07 | 30 | 96 | 5 | CID000443095 | |
| Drug | dihydroartemisinin | 1.57e-07 | 30 | 96 | 5 | CID000107770 | |
| Drug | morin | 1.63e-07 | 58 | 96 | 6 | ctd:C008548 | |
| Disease | X-11442 measurement | 3.29e-11 | 9 | 92 | 5 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.29e-11 | 9 | 92 | 5 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.29e-11 | 9 | 92 | 5 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.29e-11 | 9 | 92 | 5 | EFO_0004570, GO_0009410 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 6.57e-11 | 10 | 92 | 5 | EFO_0802185 | |
| Disease | bilirubin measurement, response to tenofovir | 6.57e-11 | 10 | 92 | 5 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 1.20e-10 | 11 | 92 | 5 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.20e-10 | 11 | 92 | 5 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 1.20e-10 | 11 | 92 | 5 | EFO_0800972 | |
| Disease | aldosterone measurement | 1.20e-10 | 11 | 92 | 5 | EFO_0010219 | |
| Disease | biliverdin measurement | 2.05e-10 | 12 | 92 | 5 | EFO_0021033 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 4.41e-10 | 5 | 92 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 4.41e-10 | 5 | 92 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 4.41e-10 | 5 | 92 | 4 | EFO_0801853 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.59e-09 | 17 | 92 | 5 | EFO_0004611, EFO_0007800 | |
| Disease | X-21339 measurement | 3.07e-09 | 7 | 92 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 6.13e-09 | 8 | 92 | 4 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.10e-08 | 9 | 92 | 4 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.10e-08 | 9 | 92 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.10e-08 | 9 | 92 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.10e-08 | 9 | 92 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.10e-08 | 9 | 92 | 4 | EFO_0020691 | |
| Disease | indoleacetate measurement | 1.83e-08 | 10 | 92 | 4 | EFO_0021015 | |
| Disease | X-21448 measurement | 1.83e-08 | 10 | 92 | 4 | EFO_0800816 | |
| Disease | X-23974 measurement | 1.83e-08 | 10 | 92 | 4 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 2.87e-08 | 11 | 92 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 2.87e-08 | 11 | 92 | 4 | EFO_0600039 | |
| Disease | blood 4-oxo-retinoic acid measurement | 2.93e-08 | 3 | 92 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 2.93e-08 | 3 | 92 | 3 | EFO_0800043 | |
| Disease | xanthurenate measurement | 2.95e-08 | 29 | 92 | 5 | EFO_0010551 | |
| Disease | response to dolutegravir | 3.54e-08 | 30 | 92 | 5 | EFO_0600017 | |
| Disease | p-cresol glucuronide measurement | 4.30e-08 | 12 | 92 | 4 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 6.19e-08 | 13 | 92 | 4 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 6.19e-08 | 13 | 92 | 4 | EFO_0800587 | |
| Disease | X-21441 measurement | 2.04e-07 | 17 | 92 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 2.62e-07 | 18 | 92 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 5.08e-07 | 21 | 92 | 4 | EFO_0010623 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 5.83e-07 | 6 | 92 | 3 | EFO_0800566 | |
| Disease | urate measurement, spine bone mineral density | 1.06e-06 | 58 | 92 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | gallstones | 1.15e-06 | 108 | 92 | 6 | EFO_0004210 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.71e-06 | 28 | 92 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | testosterone measurement | SOX1 POLR1A MAP1A UGT1A10 UGT1A8 CYP11B2 UGT1A7 RMI2 UGT1A9 BIRC6 ZFPM2 LHB TEX264 NCOA1 MINAR1 SPOCD1 | 1.91e-06 | 1275 | 92 | 16 | EFO_0004908 |
| Disease | vitamin D deficiency | 5.40e-06 | 37 | 92 | 4 | EFO_0003762 | |
| Disease | thyroxine measurement | 6.33e-06 | 83 | 92 | 5 | EFO_0005130 | |
| Disease | X-24588 measurement | 8.20e-06 | 13 | 92 | 3 | EFO_0800898 | |
| Disease | cholelithiasis | 8.43e-06 | 88 | 92 | 5 | EFO_0004799 | |
| Disease | intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies (implicated_via_orthology) | 9.62e-06 | 2 | 92 | 2 | DOID:0081262 (implicated_via_orthology) | |
| Disease | vitamin D measurement, COVID-19 | 1.68e-05 | 49 | 92 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | bilirubin measurement | 7.38e-05 | 442 | 92 | 8 | EFO_0004570 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 9.08e-05 | 28 | 92 | 3 | DOID:7998 (biomarker_via_orthology) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 9.95e-05 | 147 | 92 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | hormone measurement | 1.41e-04 | 84 | 92 | 4 | EFO_0004730 | |
| Disease | free androgen index | 1.73e-04 | 374 | 92 | 7 | EFO_0007005 | |
| Disease | dodecanedioate measurement | 6.22e-04 | 12 | 92 | 2 | EFO_0021054 | |
| Disease | serum metabolite measurement | TNPO1 HLA-DPB1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 UGT1A1 ACKR3 TXNDC16 SPOCD1 | 7.28e-04 | 945 | 92 | 10 | EFO_0005653 |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 8.54e-04 | 14 | 92 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | syndrome (implicated_via_orthology) | 1.42e-03 | 18 | 92 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 1.59e-03 | 19 | 92 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 1.59e-03 | 19 | 92 | 2 | C0587248 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 1.59e-03 | 19 | 92 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 1.59e-03 | 19 | 92 | 2 | C1275081 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.68e-03 | 75 | 92 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.75e-03 | 713 | 92 | 8 | EFO_0005689 | |
| Disease | metabolite measurement | 1.86e-03 | 560 | 92 | 7 | EFO_0004725 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.03e-03 | 80 | 92 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | LEOPARD Syndrome | 2.13e-03 | 22 | 92 | 2 | C0175704 | |
| Disease | Noonan Syndrome | 2.54e-03 | 24 | 92 | 2 | C0028326 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 2.66e-03 | 88 | 92 | 3 | EFO_0803332 | |
| Disease | Kidney Diseases | 2.66e-03 | 88 | 92 | 3 | C0022658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVMEYLSFCPMQPAS | 451 | Q7Z4L5 | |
| LMSPYCGMHSPNIEV | 3366 | Q9NR09 | |
| TVQMMAYDKLVQCPP | 316 | P54284 | |
| MLGRMANPARSPYCI | 196 | Q02338 | |
| SDCFGAMPMEQQYPP | 1581 | Q07092 | |
| LIPVADGMNEMYLRC | 441 | Q9BQL6 | |
| MPSGCGEQNMVLFAP | 966 | A8K2U0 | |
| LMVMDIVGFYLPPNS | 256 | P46098 | |
| VMLEMTPQQGDVYTC | 186 | P04440 | |
| LPYQVTGIMMSFLEP | 256 | P21730 | |
| PKMCPQLQQYEMHGP | 686 | P01023 | |
| VLPSQCYQPLMELLM | 261 | O95294 | |
| CYQPLMELLMESVQG | 266 | O95294 | |
| ACMFSQEMYGPPALR | 931 | P49792 | |
| LLQMPYGCGEQNMVL | 971 | P20742 | |
| ICNPLLYMVTMSPQV | 126 | Q15620 | |
| ICPTPNNQFMMGGRY | 401 | P20936 | |
| VLDLMCYMVLPIQDG | 516 | Q9NVR2 | |
| STMVPPGVYMRNASC | 331 | Q9NRD9 | |
| ICNPLLYMVVMTPGI | 126 | P0C7N1 | |
| VMCMYLQPPSENSQD | 256 | Q9GZK6 | |
| TQCQKMDIPFLGEMP | 156 | Q8NCW5 | |
| YEQMMLTGLGPACPT | 1971 | P78559 | |
| GYCPTMMRVLQAVLP | 56 | P01229 | |
| MYEMCLPEQEQRPPL | 741 | Q8WW38 | |
| MDRPIAGYANLCPNM | 241 | Q96KR4 | |
| QEDMPYIPLMEFSCS | 891 | Q63HM2 | |
| GPVLCGMSMDLPLYA | 721 | Q6UW60 | |
| LDSPEPMTVMVYNCA | 836 | Q9Y4D7 | |
| DGLIQMVVVMNFPYC | 156 | Q96R30 | |
| VIMANIYLLAPPVMN | 276 | Q8NH59 | |
| IIANMSGCLPYMLPP | 126 | P07202 | |
| ICVGPENMQIMYPAI | 1346 | Q7Z3U7 | |
| VMCMYLQPPSENSPD | 256 | O76002 | |
| LPCTGDYMNMSPVGD | 726 | P35568 | |
| ICNPLMYMVVMSPGI | 126 | P0C7N5 | |
| PACAYEPMDFVMALI | 191 | Q9NZH0 | |
| VAICNPLLYPVMMSN | 126 | Q9NZP5 | |
| AAAMNPCMSPMAYAP | 131 | P55317 | |
| PIEIPMCKDIGYNMT | 36 | Q9ULW2 | |
| MPRPENCPEELYNIM | 476 | P08631 | |
| YAPGLSPDTIMECAM | 166 | P13284 | |
| NVPIMYICHGMTPQN | 491 | Q6P9A2 | |
| TVMCPNMPNKSVLLY | 31 | P25106 | |
| TSMCQPPGIMQFEEP | 31 | Q8N5U1 | |
| MPLPERGMSYCPQAT | 91 | Q5JT82 | |
| YNLGGPRMVCVMLPE | 81 | P19099 | |
| MQNLGPLPNDVCLTM | 161 | Q86X24 | |
| ITLPPCIYMAPMNQS | 21 | P55286 | |
| LTYLNPMGLVTPNIM | 2311 | Q9NYQ7 | |
| KTPQMGTFMGVYLPC | 181 | Q9UHW9 | |
| SINMIPPRGCAYIVM | 536 | O95104 | |
| INMIPPRGCAYVCMV | 506 | Q9UPN6 | |
| VEMSYPGEQMILACL | 236 | P51168 | |
| MPVLREYLMSGGICP | 201 | Q96PD7 | |
| MSQQVCMQLVVGPYA | 136 | P0C626 | |
| QAPRMGTFMGVYLPC | 116 | Q9H2X9 | |
| PQPCEMQRTYFPMNI | 206 | Q9UPX6 | |
| ICNPLLYMVVMTPGI | 126 | Q8NH10 | |
| VQMSSELCPYNPVME | 491 | Q9BQF6 | |
| YVMVMGVVQACSPEP | 101 | Q96E14 | |
| CPDMYINTNEIGIPM | 446 | O95602 | |
| YNMAMAVMSPCPLLQ | 376 | Q9NQ40 | |
| LCYPQSPDMQPFIMG | 346 | Q15788 | |
| MPGGYALSQPVSCME | 371 | Q7Z5V6 | |
| PVGQMCQNPIYMQKE | 691 | Q9H156 | |
| PIVDDPYMMGRIACA | 91 | P49903 | |
| VAPYVNMGALRMPFQ | 196 | O15266 | |
| CTNYAYPTMVLELMP | 361 | Q9NY91 | |
| MEPPDQCSQYMTSLL | 1 | P0C7M4 | |
| INPYMSSPCHIEMIL | 136 | P18621 | |
| CPGDLREMISMYLPA | 336 | O00570 | |
| MPEPRYVVSMGSCAN | 141 | O75251 | |
| PSMGTLMGVYLPCLQ | 116 | Q9UP95 | |
| PDSMKVLPVYMNCLL | 836 | O94855 | |
| HFGIVPLEAMYMQCP | 326 | Q9H553 | |
| PLEAMYMQCPVIAVN | 331 | Q9H553 | |
| PCMVVGTQNPFAFLM | 116 | Q6UXD7 | |
| MNSPPGQYFSPLDCM | 246 | P55916 | |
| IMCIFYMPTVNSLPE | 16 | Q9P2K2 | |
| VLRPALPGTMMQCYL | 276 | O00295 | |
| YESICNGVPMVMMPL | 376 | Q9HAW8 | |
| MSCLDVMYQVYGPPQ | 1 | Q8N8G2 | |
| MMPYFCLDNNSPLPD | 311 | P30825 | |
| LVGPQMFMDCSPQAL | 756 | Q6ZMY3 | |
| IAEGCMQGMVPYLPE | 421 | O14787 | |
| GNMCTPQMPCSVIVY | 161 | Q6ICG8 | |
| RPIMPNMVFVGGINC | 266 | P22309 | |
| MCPLARQGDFYVPEM | 181 | Q9Y6I9 | |
| PFTCAYGLVLQVPMM | 211 | A8MV23 | |
| MEPPDQCSQYMTSLL | 1 | Q9BQY4 | |
| YESICNGVPMVMMPL | 376 | O60656 | |
| AIAEGCMQGMIPYLP | 431 | Q92973 | |
| PLSNSLMQPCYEPVM | 746 | Q5HYM0 | |
| MYMADSQCTSPGIPA | 401 | Q9BZF9 | |
| FDMTQCIGPNGYMEP | 546 | Q9UBW7 | |
| GDVCEVQLMVYNPMP | 596 | Q96Q05 | |
| IYMQMLLCPDPAVSF | 2681 | Q5T4S7 | |
| YESICNGVPMVMMPL | 376 | Q9HAW7 | |
| YESICNGVPMVMMPL | 376 | Q9HAW9 | |
| MIGPQALYMCTDINP | 66 | Q9Y5N5 |